These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 5325672)

  • 21. [On the treatment of various liver diseases by oral administration of arginine glucose-1-phosphate].
    Arrigo A
    Clin Ter; 1967 Dec; 43(6):523-41. PubMed ID: 5617980
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cholesterolemic changes after treatment with a new hepatoprotective drug in geriatric patients].
    Baldoni E; Floris E; Nuzzo L
    G Gerontol; 1968 Aug; 16(8):785-7. PubMed ID: 5740953
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of a liver prophylactic substance on trinitrotoluene poisoning].
    Ruzdić N; Stern P
    Wien Klin Wochenschr; 1966 Oct; 78(40):669-70. PubMed ID: 5972533
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the so-called hepatoprotective drugs. II. The so-called hepatoprotective drugs in the treatment of liver diseases].
    Mauro V
    Clin Ter; 1967 May; 41(3):265-86. PubMed ID: 4177978
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the problem of effects and side effects of steroids and liver hydrolysates in acute and chronic liver diseases].
    Kleine FD
    Z Arztl Fortbild (Jena); 1966 Aug; 60(15):900-4. PubMed ID: 5995281
    [No Abstract]   [Full Text] [Related]  

  • 26. [On the diagnosis and therapy of chronic hepatopathies. Experiences with Orgatract].
    Bogenhard H
    Ther Ggw; 1965 Jun; 104(6):841-53. PubMed ID: 5318048
    [No Abstract]   [Full Text] [Related]  

  • 27. [Controlled clinico-statistical studies on the role of the nucleosides in an association of hepatoprotective and anti-asthenic action].
    Soranzo ML
    Minerva Med; 1974 Feb; 65(8):391-7. PubMed ID: 4820721
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of liver cytosol fractions in treatment of acute liver failure.
    Makowka L; Falk RE; Blendis LM; Langer B; Falk JA; Rotstein LE; Phillips MJ
    Surgery; 1982 Jan; 91(1):120-2. PubMed ID: 7054900
    [No Abstract]   [Full Text] [Related]  

  • 29. [Liver extracts in the treatment of liver diseases].
    D'ORS JP; SARTE J
    Med Cir Guerra; 1955 Jan; 17(1):21-4. PubMed ID: 14382921
    [No Abstract]   [Full Text] [Related]  

  • 30. [Biological evaluation of liver protective agents with special consideration of liver preparations. 9. Practical use of prepared methods for biological evaluation of commercial liver preparations].
    Dressel H; Richter J
    Pharmazie; 1969 Sep; 24(9):555-66. PubMed ID: 5368430
    [No Abstract]   [Full Text] [Related]  

  • 31. [Considerations on the treatment with the combination of ribonucleosides, hepatic extract and vitamin B-12 (Nuclepatox) of acute and chronic liver diseases in the course of pulmonary tuberculosis].
    Ravazzoni C; Balzano E; Cuneo S
    Minerva Med; 1967 Jan; 58(6):141-7. PubMed ID: 6016918
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical trial of the intravenous administration of a combination of amino acids and of an antitoxic liver extract].
    Malvicini G; Tinozzi S
    Minerva Med; 1968 Mar; 59(19):1027-33. PubMed ID: 5646216
    [No Abstract]   [Full Text] [Related]  

  • 33. [The behavior of the sulfobromophthalein chromoelimination curves subjects with ethylic hepatopathy treated with a liver extract enriched with nucleosides of the pyrimidine series and ith cyanocobalamine].
    D'Agostino F
    Minerva Med; 1970 Oct; 61(87):4893-901. PubMed ID: 5488540
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of chronic liver diseases by crude liver extracts].
    MARKIEWICZ M; NOWAK J
    Pol Tyg Lek (Wars); 1959 Jan; 14(4):173-7. PubMed ID: 13667536
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of alcoholic liver disease: studies of 10 cases].
    Silvi G; Stellato S
    Clin Ter; 1978 Feb; 84(3):275-82. PubMed ID: 639480
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hepa-listrocol in the therapy of chronic inflammatory liver diseases].
    Baum HH
    Landarzt; 1967 Apr; 43(11):530-3. PubMed ID: 5585071
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of chronic liver diseases with crude & deproteinized liver extracts].
    SANGIORGI GB
    Minerva Med; 1957 Nov; 48(93):3895-908. PubMed ID: 13503874
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experiences with a liver preparation containing digestive enzymes. (Preliminary report)].
    Bannaski H
    ZFA (Stuttgart); 1978 Nov; 54(32):1685-6. PubMed ID: 735325
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation of therapeutic activity of a new pharmacologic combination in patients with chronic liver and debilitating diseases].
    Pasotti C; Buniva G; Carpinella G
    Clin Ter; 1971 Mar; 56(5):427-39. PubMed ID: 5564990
    [No Abstract]   [Full Text] [Related]  

  • 40. [Liver extract P.C.B].
    Tournerie J
    J Med Bord; 1965 Apr; 142(4):726-9. PubMed ID: 5318698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.